Arginine
•Last Updated: January 18 2023
Arginine is an amino acid involved in the regulation of vascular function and blood flow. Supplementation may improve high blood pressure and erectile dysfunction.
Arginine is most often used for
Last Updated: January 18 2023
Arginine, also called L-arginine, is an amino acid used by the body as a protein building block. It’s also an intermediate metabolite in the urea cycle and the nitric oxide cycle.[176][177][178] The urea cycle removes excess ammonia, a toxic molecule, from the body, and the nitric oxide cycle produces nitric oxide, which is an important signaling molecule involved in vascular function.[176][177][178] Although the body can synthesize arginine, it can also be obtained in the diet through protein-containing foods or dietary supplements.[176][177][178]
Daily supplementation with arginine can reduce blood pressure in people with healthy blood pressure and people with hypertension (high blood pressure).[179] Evidence also supports the use of arginine to help improve birth outcomes in pregnant women with conditions like hypertension and preeclampsia or a history of poor pregnancy outcomes. This includes reducing the risk of infants small for gestational age[180] and intrauterine growth restriction of the baby.[181] Arginine can also improve maternal outcomes by reducing the risk of preeclampsia in the pregnant mother.[182][183] Additionally, arginine can reduce blood triglycerides,[184][185] particularly in people older than 50 or in people with metabolic syndrome or type 2 diabetes.[184]
In men with erectile dysfunction, daily supplementation with arginine can alleviate symptoms.[186] Furthermore, the combination of arginine with phosphodiesterase type 5 inhibitors (PDE5Is), like Viagra, improves sexual function in men with erectile dysfunction more than treatment with PDE5Is alone.[187]
Evidence also shows that daily supplementation with arginine might increase VO2max, but the magnitude of improvement is negligible and unlikely to be clinically meaningful.[188] Furthermore, most studies find no beneficial effect of arginine on exercise performance.[189] It is only when highly-varied types of exercise (aerobic, anaerobic, resistance, etc.) and performance outcomes (time-to-exhaustion, time-trials, sprint time, 1-rep-max, reps-to-failure, etc.) are inappropriately pooled that meta-analyses find a performance benefit from arginine.[189]
Animal studies show that neither oral nor intravenous delivery of arginine causes toxicity, even at high doses.[190][191] However, supplementation with arginine has been reported to cause adverse gastrointestinal effects in humans, including nausea, vomiting, and diarrhea.[192] For this reason, upper limit guidelines of approximately 20 to 30 grams per day have been proposed for supplemental arginine intake,[193][194] but more long-term safety data in humans are needed to accurately define a tolerable upper intake level.
Nitric oxide is a key molecule involved in vasodilation, i.e., the relaxation and widening of blood vessels to increase blood flow to tissues that lack oxygen or nutrients.[195][177] The beneficial effects of arginine on high blood pressure[179][182][183] and erectile dysfunction[186][187] are likely related to vasodilation because arginine increases nitric oxide synthesis.[195][177][178]
A similar mechanism may explain how arginine might increase VO2max.[196][197][188] Additionally, nitric oxide might have direct effects on muscle contractile function.[196][198] Furthermore, arginine’s role in the urea cycle helps with ammonia excretion[176], the accumulation of which might induce fatigue during exercise.[199][200][201]
Note that Arginine is also known as:
- L-Arginine
The standard preworkout dose for arginine is 3–6 grams.
Taking more than 10 grams of arginine at once can result in gastrointestinal distress and diarrhea, but it is possible to maintain elevated arginine levels throughout the day by taking three spaced doses (15–18 grams/day). However, citrulline supplementation is more effective at maintaining elevated arginine levels for long periods of time.
What works and what doesn't?
Unlock the full potential of Examine
Latest ResearchRead all studies
3.^Malinauskas BM, Overton RF, Carraway VG, Cash BCSupplements of interest for sport-related injury and sources of supplement information among college athletesAdv Med Sci.(2007)
4.^Tharakan JF, Yu YM, Zurakowski D, Roth RM, Young VR, Castillo LAdaptation to a long term (4 weeks) arginine- and precursor (glutamate, proline and aspartate)-free dietClin Nutr.(2008 Aug)
5.^de Jonge WJ, Hallemeesch MM, Kwikkers KL, Ruijter JM, de Gier-de Vries C, van Roon MA, Meijer AJ, Marescau B, de Deyn PP, Deutz NE, Lamers WHOverexpression of arginase I in enterocytes of transgenic mice elicits a selective arginine deficiency and affects skin, muscle, and lymphoid developmentAm J Clin Nutr.(2002 Jul)
6.^de Jonge WJ, Kwikkers KL, te Velde AA, van Deventer SJ, Nolte MA, Mebius RE, Ruijter JM, Lamers MC, Lamers WHArginine deficiency affects early B cell maturation and lymphoid organ development in transgenic miceJ Clin Invest.(2002 Nov)
7.^de Jonge WJ, Marescau B, D'Hooge R, De Deyn PP, Hallemeesch MM, Deutz NE, Ruijter JM, Lamers WHOverexpression of arginase alters circulating and tissue amino acids and guanidino compounds and affects neuromotor behavior in miceJ Nutr.(2001 Oct)
8.^Kwikkers KL, Ruijter JM, Labruyère WT, McMahon KK, Lamers WHEffect of arginine deficiency on arginine-dependent post-translational protein modifications in miceBr J Nutr.(2005 Feb)
9.^Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM Jr, Gladwin MTDysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell diseaseJAMA.(2005 Jul 6)
11.^Schramm L, La M, Heidbreder E, Hecker M, Beckman JS, Lopau K, Zimmermann J, Rendl J, Reiners C, Winderl S, Wanner C, Schmidt HHL-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantationKidney Int.(2002 Apr)
14.^De Bandt JP, Cynober L, Lim SK, Coudray-Lucas C, Poupon R, Giboudeau JMetabolism of ornithine, alpha-ketoglutarate and arginine in isolated perfused rat liverBr J Nutr.(1995 Feb)
15.^Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Bénazeth S, Cynober LAlmost all about citrulline in mammalsAmino Acids.(2005 Nov)
17.^Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Crespo PS, Santer R, Servais A, Valayannopoulos V, Lindner M, Rubio V, Dionisi-Vici CSuggested guidelines for the diagnosis and management of urea cycle disordersOrphanet J Rare Dis.(2012 May 29)
18.^Bommarius AS, Makryaleas K, Drauz KAn enzymatic route to L-ornithine from L-arginine--activation and stabilization studies on L-arginaseBiomed Biochim Acta.(1991)
19.^Bommarius AS, Drauz KAn enzymatic route to L-ornithine from arginine--activation, selectivity and stabilization of L-arginaseBioorg Med Chem.(1994 Jul)
20.^Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.()
21.^Dai Z, Wu Z, Yang Y, Wang J, Satterfield MC, Meininger CJ, Bazer FW, Wu GNitric oxide and energy metabolism in mammalsBiofactors.(2013 Mar 29)
22.^Molderings GJ, Haenisch BAgmatine (decarboxylated L-arginine): physiological role and therapeutic potentialPharmacol Ther.(2012 Mar)
23.^Regunathan S, Reis DJCharacterization of arginine decarboxylase in rat brain and liver: distinction from ornithine decarboxylaseJ Neurochem.(2000 May)
24.^Raasch W, Regunathan S, Li G, Reis DJAgmatine, the bacterial amine, is widely distributed in mammalian tissuesLife Sci.(1995)
25.^Raasch W, Regunathan S, Li G, Reis DJAgmatine is widely and unequally distributed in rat organsAnn N Y Acad Sci.(1995 Jul 12)
26.^Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJAgmatine: an endogenous clonidine-displacing substance in the brainScience.(1994 Feb 18)
27.^Bode-Böger SM, Böger RH, Galland A, Tsikas D, Frölich JCL-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationshipBr J Clin Pharmacol.(1998 Nov)
28.^Tangphao O, Grossmann M, Chalon S, Hoffman BB, Blaschke TFPharmacokinetics of intravenous and oral L-arginine in normal volunteersBr J Clin Pharmacol.(1999 Mar)
29.^White MF, Christensen HNThe two-way flux of cationic amino acids across the plasma membrane of mammalian cells is largely explained by a single transport systemJ Biol Chem.(1982 Sep 10)
30.^White MF, Gazzola GC, Christensen HNCationic amino acid transport into cultured animal cells. I. Influx into cultured human fibroblastsJ Biol Chem.(1982 Apr 25)
31.^MacLeod CLRegulation of cationic amino acid transporter (CAT) gene expressionBiochem Soc Trans.(1996 Aug)
32.^MacLeod CL, Finley KD, Kakuda DKy(+)-type cationic amino acid transport: expression and regulation of the mCAT genesJ Exp Biol.(1994 Nov)
33.^Identification and Characterization of a Membrane Protein (y+L Amino Acid Transporter-1) That Associates with 4F2hc to Encode the Amino Acid Transport Activity y+L A CANDIDATE GENE FOR LYSINURIC PROTEIN INTOLERANCE.()
34.^Verrey F, Jack DL, Paulsen IT, Saier MH Jr, Pfeiffer RNew glycoprotein-associated amino acid transportersJ Membr Biol.(1999 Dec 1)
35.^Dall'Asta V, Bussolati O, Sala R, Rotoli BM, Sebastio G, Sperandeo MP, Andria G, Gazzola GCArginine transport through system y(+)L in cultured human fibroblasts: normal phenotype of cells from LPI subjectsAm J Physiol Cell Physiol.(2000 Dec)
36.^Collier SR, Casey DP, Kanaley JAGrowth hormone responses to varying doses of oral arginineGrowth Horm IGF Res.(2005 Apr)
37.^Jabecka A, Ast J, Bogdaski P, Drozdowski M, Pawlak-Lemaska K, Cielewicz AR, Pupek-Musialik DOral L-arginine supplementation in patients with mild arterial hypertension and its effect on plasma level of asymmetric dimethylarginine, L-citruline, L-arginine and antioxidant statusEur Rev Med Pharmacol Sci.(2012 Nov)
38.^Wilson AM, Harada R, Nair N, Balasubramanian N, Cooke JPL-arginine supplementation in peripheral arterial disease: no benefit and possible harmCirculation.(2007 Jul 10)
39.^Teerlink TLetter by Teerlink regarding article, "L-arginine supplementation in peripheral arterial disease: no benefit and possible harm"Circulation.(2008 Feb 12)
40.^Bliss TV, Collingridge GLA synaptic model of memory: long-term potentiation in the hippocampusNature.(1993 Jan 7)
41.^Hawkins RD, Kandel ER, Siegelbaum SALearning to modulate transmitter release: themes and variations in synaptic plasticityAnnu Rev Neurosci.(1993)
43.^Schuman EM, Madison DVA requirement for the intercellular messenger nitric oxide in long-term potentiationScience.(1991 Dec 6)
44.^Arancio O, Kiebler M, Lee CJ, Lev-Ram V, Tsien RY, Kandel ER, Hawkins RDNitric oxide acts directly in the presynaptic neuron to produce long-term potentiation in cultured hippocampal neuronsCell.(1996 Dec 13)
45.^Bartus K, Pigott B, Garthwaite JCellular targets of nitric oxide in the hippocampusPLoS One.(2013)
46.^O'Dell TJ, Huang PL, Dawson TM, Dinerman JL, Snyder SH, Kandel ER, Fishman MCEndothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOSScience.(1994 Jul 22)
47.^Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity.()
48.^Son H, Hawkins RD, Martin K, Kiebler M, Huang PL, Fishman MC, Kandel ERLong-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthaseCell.(1996 Dec 13)
49.^Sakoda T, Hirata K, Kuroda R, Miki N, Suematsu M, Kawashima S, Yokoyama MMyristoylation of endothelial cell nitric oxide synthase is important for extracellular release of nitric oxideMol Cell Biochem.(1995 Nov 22)
50.^Kantor DB, Lanzrein M, Stary SJ, Sandoval GM, Smith WB, Sullivan BM, Davidson N, Schuman EMA role for endothelial NO synthase in LTP revealed by adenovirus-mediated inhibition and rescueScience.(1996 Dec 6)
51.^Lameu C, de Camargo AC, Faria ML-arginine signalling potential in the brain: the peripheral gets centralRecent Pat CNS Drug Discov.(2009 Jun)
52.^Flam BR, Eichler DC, Solomonson LPEndothelial nitric oxide production is tightly coupled to the citrulline-NO cycleNitric Oxide.(2007 Nov-Dec)
53.^Xie L, Gross SSArgininosuccinate synthetase overexpression in vascular smooth muscle cells potentiates immunostimulant-induced NO productionJ Biol Chem.(1997 Jun 27)
54.^Husson A, Brasse-Lagnel C, Fairand A, Renouf S, Lavoinne AArgininosuccinate synthetase from the urea cycle to the citrulline-NO cycleEur J Biochem.(2003 May)
55.^Matarredona ER, Murillo-Carretero M, Moreno-López B, Estrada CNitric oxide synthesis inhibition increases proliferation of neural precursors isolated from the postnatal mouse subventricular zoneBrain Res.(2004 Jan 9)
58.^Hsieh HY, Robertson CL, Vermehren-Schmaedick A, Balkowiec ANitric oxide regulates BDNF release from nodose ganglion neurons in a pattern-dependent and cGMP-independent mannerJ Neurosci Res.(2010 May 1)
59.^Lameu C, Trujillo CA, Schwindt TT, Negraes PD, Pillat MM, Morais KL, Lebrun I, Ulrich HInteractions between the NO-citrulline cycle and brain-derived neurotrophic factor in differentiation of neural stem cellsJ Biol Chem.(2012 Aug 24)
60.^Kirschbaum C, Pirke KM, Hellhammer DHThe 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory settingNeuropsychobiology.(1993)
61.^Jezova D, Makatsori A, Smriga M, Morinaga Y, Duncko RSubchronic treatment with amino acid mixture of L-lysine and L-arginine modifies neuroendocrine activation during psychosocial stress in subjects with high trait anxietyNutr Neurosci.(2005 Jun)
62.^Jezova D, Makatsori A, Duncko R, Moncek F, Jakubek MHigh trait anxiety in healthy subjects is associated with low neuroendocrine activity during psychosocial stressProg Neuropsychopharmacol Biol Psychiatry.(2004 Dec)
63.^Smriga M, Ando T, Akutsu M, Furukawa Y, Miwa K, Morinaga YOral treatment with L-lysine and L-arginine reduces anxiety and basal cortisol levels in healthy humansBiomed Res.(2007 Apr)
65.^Lysine fortification reduces anxiety and lessens stress in family members in economically weak communities in northwest Syria.()
66.^Chang YF, Gao XML-lysine is a barbiturate-like anticonvulsant and modulator of the benzodiazepine receptorNeurochem Res.(1995 Aug)
67.^Hasler WLLysine as a serotonin receptor antagonist: using the diet to modulate gut functionGastroenterology.(2004 Sep)
68.^Smriga M, Torii KL-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in ratsProc Natl Acad Sci U S A.(2003 Dec 23)
69.^Smriga M, Torii KProlonged treatment with L-lysine and L-arginine reduces stress-induced anxiety in an elevated plus mazeNutr Neurosci.(2003 Apr)
70.^Joung HY, Jung EY, Kim K, Lee MS, Her S, Shim IThe differential role of NOS inhibitors on stress-induced anxiety and neuroendocrine alterations in the ratBehav Brain Res.(2012 Dec 1)
71.^Malinski TNitric oxide and nitroxidative stress in Alzheimer's diseaseJ Alzheimers Dis.(2007 May)
72.^McCann SM, Mastronardi C, de Laurentiis A, Rettori VThe nitric oxide theory of aging revisitedAnn N Y Acad Sci.(2005 Dec)
73.^Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AMNitric oxide in the central nervous system: neuroprotection versus neurotoxicityNat Rev Neurosci.(2007 Oct)
74.^Rushaidhi M, Jing Y, Kennard JT, Collie ND, Williams JM, Zhang H, Liu PAging affects L-arginine and its metabolites in memory-associated brain structures at the tissue and synaptoneurosome levelsNeuroscience.(2012 May 3)
75.^Liu P, Jing Y, Zhang HAge-related changes in arginine and its metabolites in memory-associated brain structuresNeuroscience.(2009 Dec 1)
77.^Greenwood PMFunctional plasticity in cognitive aging: review and hypothesisNeuropsychology.(2007 Nov)
78.^Stuehr DJStructure-function aspects in the nitric oxide synthasesAnnu Rev Pharmacol Toxicol.(1997)
79.^Charles IG, Scorer CA, Moro MA, Fernàndez C, Chubb A, Dawson J, Foxwell N, Knowles RG, Baylis SAExpression of human nitric oxide synthase isozymesMethods Enzymol.(1996)
80.^Casas JP, Cavalleri GL, Bautista LE, Smeeth L, Humphries SE, Hingorani ADEndothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE reviewAm J Epidemiol.(2006 Nov 15)
81.^Griffith OW, Stuehr DJNitric oxide synthases: properties and catalytic mechanismAnnu Rev Physiol.(1995)
84.^Mayer B, John M, Heinzel B, Werner ER, Wachter H, Schultz G, Böhme EBrain nitric oxide synthase is a biopterin- and flavin-containing multi-functional oxido-reductaseFEBS Lett.(1991 Aug 19)
85.^Hevel JM, White KA, Marletta MAPurification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoproteinJ Biol Chem.(1991 Dec 5)
86.^Stuehr DJ, Cho HJ, Kwon NS, Weise MF, Nathan CFPurification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoproteinProc Natl Acad Sci U S A.(1991 Sep 1)
87.^Mayer B, Hemmens BBiosynthesis and action of nitric oxide in mammalian cellsTrends Biochem Sci.(1997 Dec)
88.^Ghosh DK, Abu-Soud HM, Stuehr DJReconstitution of the second step in NO synthesis using the isolated oxygenase and reductase domains of macrophage NO synthaseBiochemistry.(1995 Sep 12)
89.^Lekakis JP, Papathanassiou S, Papaioannou TG, Papamichael CM, Zakopoulos N, Kotsis V, Dagre AG, Stamatelopoulos K, Protogerou A, Stamatelopoulos SFOral L-arginine improves endothelial dysfunction in patients with essential hypertensionInt J Cardiol.(2002 Dec)
91.^Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, Fermo I, Rabaiotti G, Gatti R, Piatti PBeneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patientsAm J Physiol Endocrinol Metab.(2006 Nov)
92.^Acute L-arginine supplementation reduces the O2 cost of moderate-intensity exercise and enhances high-intensity exercise tolerance.()
93.^Fahs CA, Heffernan KS, Fernhall BHemodynamic and vascular response to resistance exercise with L-arginineMed Sci Sports Exerc.(2009 Apr)
94.^Tang JE, Lysecki PJ, Manolakos JJ, MacDonald MJ, Tarnopolsky MA, Phillips SMBolus arginine supplementation affects neither muscle blood flow nor muscle protein synthesis in young men at rest or after resistance exerciseJ Nutr.(2011 Feb)
95.^Alvares TS, Conte CA, Paschoalin VM, Silva JT, Meirelles Cde M, Bhambhani YN, Gomes PSAcute l-arginine supplementation increases muscle blood volume but not strength performanceAppl Physiol Nutr Metab.(2012 Feb)
96.^Durante W, Johnson FK, Johnson RAArginase: a critical regulator of nitric oxide synthesis and vascular functionClin Exp Pharmacol Physiol.(2007 Sep)
97.^Baydoun AR, Emery PW, Pearson JD, Mann GESubstrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cellsBiochem Biophys Res Commun.(1990 Dec 31)
98.^Palmer RM, Ashton DS, Moncada SVascular endothelial cells synthesize nitric oxide from L-arginineNature.(1988 Jun 16)
99.^Cardounel AJ, Cui H, Samouilov A, Johnson W, Kearns P, Tsai AL, Berka V, Zweier JLEvidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular functionJ Biol Chem.(2007 Jan 12)
100.^Hardy TA, May JMCoordinate regulation of L-arginine uptake and nitric oxide synthase activity in cultured endothelial cellsFree Radic Biol Med.(2002 Jan 15)
101.^Bode-Böger SM, Scalera F, Ignarro LJThe L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratioPharmacol Ther.(2007 Jun)
102.^Shin S, Mohan S, Fung HLIntracellular L-arginine concentration does not determine NO production in endothelial cells: implications on the "L-arginine paradox"Biochem Biophys Res Commun.(2011 Nov 4)
103.^Liu TH, Wu CL, Chiang CW, Lo YW, Tseng HF, Chang CKNo effect of short-term arginine supplementation on nitric oxide production, metabolism and performance in intermittent exercise in athletesJ Nutr Biochem.(2009 Jun)
104.^Tsukahara H, Gordienko DV, Goligorsky MSContinuous monitoring of nitric oxide release from human umbilical vein endothelial cellsBiochem Biophys Res Commun.(1993 Jun 15)
105.^Joshi MS, Ferguson TB Jr, Johnson FK, Johnson RA, Parthasarathy S, Lancaster JR JrReceptor-mediated activation of nitric oxide synthesis by arginine in endothelial cellsProc Natl Acad Sci U S A.(2007 Jun 12)
106.^McDonald KK, Zharikov S, Block ER, Kilberg MSA caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox"J Biol Chem.(1997 Dec 12)
107.^Zani BG, Bohlen HGTransport of extracellular l-arginine via cationic amino acid transporter is required during in vivo endothelial nitric oxide productionAm J Physiol Heart Circ Physiol.(2005 Oct)
108.^Kone BCProtein-protein interactions controlling nitric oxide synthasesActa Physiol Scand.(2000 Jan)
109.^Vallance P, Leone A, Calver A, Collier J, Moncada SAccumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureLancet.(1992 Mar 7)
110.^Böger RH, Bode-Böger SM, Thiele W, Creutzig A, Alexander K, Frölich JCRestoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive diseaseJ Am Coll Cardiol.(1998 Nov)
111.^Mittermayer F, Krzyzanowska K, Exner M, Mlekusch W, Amighi J, Sabeti S, Minar E, Müller M, Wolzt M, Schillinger MAsymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery diseaseArterioscler Thromb Vasc Biol.(2006 Nov)
114.^Kielstein JT, Impraim B, Simmel S, Bode-Böger SM, Tsikas D, Frölich JC, Hoeper MM, Haller H, Fliser DCardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humansCirculation.(2004 Jan 20)
116.^Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Charles IG, Whitley GS, Vallance PIdentification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminasesBiochem J.(1999 Oct 1)
117.^Jacobi J, Sydow K, von Degenfeld G, Zhang Y, Dayoub H, Wang B, Patterson AJ, Kimoto M, Blau HM, Cooke JPOverexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesisCirculation.(2005 Mar 22)
118.^Stühlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JPHomocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginineCirculation.(2001 Nov 20)
119.^Drexler H, Zeiher AM, Meinzer K, Just HCorrection of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginineLancet.(1991 Dec 21-28)
120.^Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JPNovel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolaseCirculation.(1999 Jun 22)
121.^Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JPImpaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolaseCirculation.(2002 Aug 20)
122.^Willoughby DS, Boucher T, Reid J, Skelton G, Clark MEffects of 7 days of arginine-alpha-ketoglutarate supplementation on blood flow, plasma L-arginine, nitric oxide metabolites, and asymmetric dimethyl arginine after resistance exerciseInt J Sport Nutr Exerc Metab.(2011 Aug)
123.^Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A, Spickler W, Schulze F, Böger RHPharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolismBr J Clin Pharmacol.(2008 Jan)
124.^Ochiai M, Hayashi T, Morita M, Ina K, Maeda M, Watanabe F, Morishita KShort-term effects of L-citrulline supplementation on arterial stiffness in middle-aged menInt J Cardiol.(2012 Mar 8)
125.^Figueroa A, Sanchez-Gonzalez MA, Wong A, Arjmandi BHWatermelon extract supplementation reduces ankle blood pressure and carotid augmentation index in obese adults with prehypertension or hypertensionAm J Hypertens.(2012 Jun)
126.^Bode-Böger SM, Böger RH, Alfke H, Heinzel D, Tsikas D, Creutzig A, Alexander K, Frölich JCL-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled studyCirculation.(1996 Jan 1)
127.^Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M, Ullrich V, Mülsch A, Schulz E, Keaney JF Jr, Stamler JS, Münzel TCentral role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-toleranceJ Clin Invest.(2004 Feb)
128.^Witte DR, van der Graaf Y, Grobbee DE, Bots ML; SMART Study GroupMeasurement of flow-mediated dilatation of the brachial artery is affected by local elastic vessel wall properties in high-risk patientsAtherosclerosis.(2005 Oct)
129.^Lind LArterial compliance influences the measurement of flow-mediated vasodilation, but not acetylcholine-mediated forearm blood flow. The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) studyAtherosclerosis.(2007 Jan)
130.^Vasilijevic A, Buzadzic B, Korac A, Petrovic V, Jankovic A, Korac BBeneficial effects of L-arginine nitric oxide-producing pathway in rats treated with alloxanJ Physiol.(2007 Nov 1)
131.^Méndez JD, Hernández Rde HL-arginine and polyamine administration protect beta-cells against alloxan diabetogenic effect in Sprague-Dawley ratsBiomed Pharmacother.(2005 Jul)
132.^Mohan IK, Das UNEffect of L-arginine-nitric oxide system on chemical-induced diabetes mellitusFree Radic Biol Med.(1998 Nov 1)
133.^Lindsay RM, Smith W, Rossiter SP, McIntyre MA, Williams BC, Baird JDN omega-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E ratsDiabetes.(1995 Mar)
134.^Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi NApoptotic cell death triggered by nitric oxide in pancreatic beta-cellsDiabetes.(1995 Jul)
135.^DiMagno MJ, Hao Y, Tsunoda Y, Williams JA, Owyang CSecretagogue-stimulated pancreatic secretion is differentially regulated by constitutive NOS isoforms in miceAm J Physiol Gastrointest Liver Physiol.(2004 Mar)
136.^Monti LD, Setola E, Lucotti PC, Marrocco-Trischitta MM, Comola M, Galluccio E, Poggi A, Mammì S, Catapano AL, Comi G, Chiesa R, Bosi E, Piatti PMEffect of a long-term oral l-arginine supplementation on glucose metabolism: a randomized, double-blind, placebo-controlled trialDiabetes Obes Metab.(2012 Oct)
137.^Tang WH, Wang Z, Cho L, Brennan DM, Hazen SLDiminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular riskJ Am Coll Cardiol.(2009 Jun 2)
138.^Sourij H, Meinitzer A, Pilz S, Grammer TB, Winkelmann BR, Boehm BO, März WArginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiographyAtherosclerosis.(2011 Sep)
139.^Jabłecka A, Bogdański P, Balcer N, Cieślewicz A, Skołuda A, Musialik KThe effect of oral L-arginine supplementation on fasting glucose, HbA1c, nitric oxide and total antioxidant status in diabetic patients with atherosclerotic peripheral arterial disease of lower extremitiesEur Rev Med Pharmacol Sci.(2012 Mar)
140.^Álvares TS, Meirelles CM, Bhambhani YN, Paschoalin VM, Gomes PSL-Arginine as a potential ergogenic aid in healthy subjectsSports Med.(2011 Mar 1)
141.^Long JH, Lira VA, Soltow QA, Betters JL, Sellman JE, Criswell DSArginine supplementation induces myoblast fusion via augmentation of nitric oxide productionJ Muscle Res Cell Motil.(2006)
142.^Maxwell AJ, Ho HV, Le CQ, Lin PS, Bernstein D, Cooke JPL-arginine enhances aerobic exercise capacity in association with augmented nitric oxide productionJ Appl Physiol.(2001 Mar)
143.^Schaefer A, Piquard F, Geny B, Doutreleau S, Lampert E, Mettauer B, Lonsdorfer JL-arginine reduces exercise-induced increase in plasma lactate and ammoniaInt J Sports Med.(2002 Aug)
144.^Wax B, Kavazis AN, Webb HE, Brown SPAcute L-arginine alpha ketoglutarate supplementation fails to improve muscular performance in resistance trained and untrained menJ Int Soc Sports Nutr.(2012 Apr 17)
145.^Buford BN, Koch AJGlycine-arginine-alpha-ketoisocaproic acid improves performance of repeated cycling sprintsMed Sci Sports Exerc.(2004 Apr)
146.^Stevens BR, Godfrey MD, Kaminski TW, Braith RWHigh-intensity dynamic human muscle performance enhanced by a metabolic interventionMed Sci Sports Exerc.(2000 Dec)
147.^Abel T, Knechtle B, Perret C, Eser P, von Arx P, Knecht HInfluence of chronic supplementation of arginine aspartate in endurance athletes on performance and substrate metabolism - a randomized, double-blind, placebo-controlled studyInt J Sports Med.(2005 Jun)
148.^Colombani PC, Bitzi R, Frey-Rindova P, Frey W, Arnold M, Langhans W, Wenk CChronic arginine aspartate supplementation in runners reduces total plasma amino acid level at rest and during a marathon runEur J Nutr.(1999 Dec)
149.^McConell GKEffects of L-arginine supplementation on exercise metabolismCurr Opin Clin Nutr Metab Care.(2007 Jan)
150.^McKnight JR, Satterfield MC, Jobgen WS, Smith SB, Spencer TE, Meininger CJ, McNeal CJ, Wu GBeneficial effects of L-arginine on reducing obesity: potential mechanisms and important implications for human healthAmino Acids.(2010 Jul)
151.^Zajac A, Poprzecki S, Zebrowska A, Chalimoniuk M, Langfort JArginine and ornithine supplementation increases growth hormone and insulin-like growth factor-1 serum levels after heavy-resistance exercise in strength-trained athletesJ Strength Cond Res.(2010 Apr)
154.^Marcell TJ, Taaffe DR, Hawkins SA, Tarpenning KM, Pyka G, Kohlmeier L, Wiswell RA, Marcus ROral arginine does not stimulate basal or augment exercise-induced GH secretion in either young or old adultsJ Gerontol A Biol Sci Med Sci.(1999 Aug)
155.^Borst SE, Millard WJ, Lowenthal DTGrowth hormone, exercise, and aging: the future of therapy for the frail elderlyJ Am Geriatr Soc.(1994 May)
156.^Fogelholm GM, Näveri HK, Kiilavuori KT, Härkönen MHLow-dose amino acid supplementation: no effects on serum human growth hormone and insulin in male weightliftersInt J Sport Nutr.(1993 Sep)
157.^Veldhuis JD, Bowers CYRegulated recovery of pulsatile growth hormone secretion from negative feedback: a preclinical investigationAm J Physiol Regul Integr Comp Physiol.(2011 Oct)
158.^Veldhuis JD, Anderson SM, Shah N, Bray M, Vick T, Gentili A, Mulligan T, Johnson ML, Weltman A, Evans WS, Iranmanesh ANeurophysiological regulation and target-tissue impact of the pulsatile mode of growth hormone secretion in the humanGrowth Horm IGF Res.(2001 Jun)
159.^Besset A, Bonardet A, Rondouin G, Descomps B, Passouant PIncrease in sleep related GH and Prl secretion after chronic arginine aspartate administration in manActa Endocrinol (Copenh).(1982 Jan)
160.^Barbul A, Lazarou SA, Efron DT, Wasserkrug HL, Efron GArginine enhances wound healing and lymphocyte immune responses in humansSurgery.(1990 Aug)
161.^Shi HP, Most D, Efron DT, Witte MB, Barbul ASupplemental L-arginine enhances wound healing in diabetic ratsWound Repair Regen.(2003 May-Jun)
162.^Debats IB, Wolfs TG, Gotoh T, Cleutjens JP, Peutz-Kootstra CJ, van der Hulst RRRole of arginine in superficial wound healing in manNitric Oxide.(2009 Nov-Dec)
163.^Shi HP, Efron DT, Most D, Tantry US, Barbul ASupplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout miceSurgery.(2000 Aug)
164.^Shi HP, Fishel RS, Efron DT, Williams JZ, Fishel MH, Barbul AEffect of supplemental ornithine on wound healingJ Surg Res.(2002 Aug)
165.^Campbell B, Roberts M, Kerksick C, Wilborn C, Marcello B, Taylor L, Nassar E, Leutholtz B, Bowden R, Rasmussen C, Greenwood M, Kreider RPharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult menNutrition.(2006 Sep)
166.^Cynober L, Coudray-Lucas C, de Bandt JP, Guéchot J, Aussel C, Salvucci M, Giboudeau JAction of ornithine alpha-ketoglutarate, ornithine hydrochloride, and calcium alpha-ketoglutarate on plasma amino acid and hormonal patterns in healthy subjectsJ Am Coll Nutr.(1990 Feb)
167.^Moinard C, Nicolis I, Neveux N, Darquy S, Bénazeth S, Cynober LDose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic studyBr J Nutr.(2008 Apr)
168.^Rougé C, Des Robert C, Robins A, Le Bacquer O, Volteau C, De La Cochetière MF, Darmaun DManipulation of citrulline availability in humansAm J Physiol Gastrointest Liver Physiol.(2007 Nov)
169.^Thibault R, Flet L, Vavasseur F, Lemerle M, Ferchaud-Roucher V, Picot D, Darmaun DOral citrulline does not affect whole body protein metabolism in healthy human volunteers: results of a prospective, randomized, double-blind, cross-over studyClin Nutr.(2011 Dec)
170.^Sureda A, Córdova A, Ferrer MD, Pérez G, Tur JA, Pons AL-citrulline-malate influence over branched chain amino acid utilization during exerciseEur J Appl Physiol.(2010 Sep)
171.^Isidori A, Lo Monaco A, Cappa MA study of growth hormone release in man after oral administration of amino acidsCurr Med Res Opin.(1981)
172.^Corpas E, Blackman MR, Roberson R, Scholfield D, Harman SMOral arginine-lysine does not increase growth hormone or insulin-like growth factor-I in old menJ Gerontol.(1993 Jul)
173.^Shao A, Hathcock JNRisk assessment for the amino acids taurine, L-glutamine and L-arginineRegul Toxicol Pharmacol.(2008 Apr)
174.^Hellier MD, Holdsworth CD, Perrett DDibasic amino acid absorption in manGastroenterology.(1973 Oct)
175.^Izzo AA, Mascolo N, Capasso FNitric oxide as a modulator of intestinal water and electrolyte transportDig Dis Sci.(1998 Aug)
Primary Use
Secondary Use